BBA Presenting on the Optimal Approach to Clinical Evaluation Process

BBA Presenting on the Optimal Approach to Clinical Evaluation Process

President and CEO of BBA Israel, Tami Abudi will present on the Optimal Approach to Clinical Evaluation Reports. She will review how the clinical evaluation process has changed over time, understanding the requirements and placing them into practice and discuss case examples from product development, Pre-CE marking and updates during the post-market phase. This presentation was given at the Arena Outsourcing in Clinical Trials – March 21-21, in Tel Aviv, Israel.

To view the full program details you may download a PDF of the presentation.

If you would like more information about work that BBA is currently doing with the FDA in the EFS program, contact us at info@bbacro.com.

Be sure to follow us on twitter at https://twitter.com/BBA_CRO and LinkedIn at https://www.linkedin.com/company-beta/1312584/.

Tags:
,
Mack Rubley
mrubley@boston-biomedical.com

Comments

No Comments

Post A Comment

MENU